-
4,4'-(1,3-Phenylenedioxy)dianiline 2479-46-1
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Materialen skiekunde |Polyimide monomeren |
4,4'-(1,3-Phenylenedioxy)dianiline|CAS:2479-46-1 |C18H16N2O2
-
4,4'-(4,4'-isopropylidendifenyl-1,1'-diyldioxy)dianiline 13080-86-9
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Yndustriële Material Chemistry |Polyimide monomeren |4,4'-(4,4'-isopropylidedifenyl-1,1'-diyldioksy)dianiline |CAS:13080-86-9 |C27H26N2O2
-
(S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethylethylester 109010-60-8
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |S-ATBA |CAS: 109010-60-8 |C16H22N2O3
-
(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate 1423058-53-0
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Neurologyske sykten |Antiepileptika |(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate |CAS:1423058-53-0 |C15H22N2O8
-
Lacosamide 175481-36-4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Neurologyske sykten |Antiepileptika |Lacosamide |CAS:175481-36-4 |C13H18N2O3
-
4-(2-Dimethylamino)ethoxybenzylamine 20059-73-8
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Digestive systeem drugs |Itopride hydrochloride en syn intermediates |4-(2-Dimethylamino)ethoxybenzylamine |CAS:20059-73-8 |C11H18N2O
-
Itopride 122898-67-3
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Digestive systeem drugs |Itopride hydrochloride en syn intermediates |Itopride |CAS:122898-67-3 |C20H26N2O4
-
2-(2-Ethoxyphenoxy)ethylbromide 3259-03-8
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Prostatyske Hyperplasia Drugs |Tamsulosin Hydrochloride Intermediates |CAS:3259-03-8 |C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Prostatyske Hyperplasia Drugs |Tamsulosin Hydrochloride Intermediates |CAS:116091-63-5 |C10H13NO4S
-
4-(4-Phenylbutoksy)benzoëzuur 30131-16-9
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Respiratory sykten |Pranlukast Intermediates |4-(4-Fenylbutoksy)benzoëzuur |CAS:30131-16-9 |C17H18O3
-
3'-[4-(4-Fenylbutoksy)benzoylamino]-2'-hydroxyacetofenon 136450-06-1
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Respiratory sykten |Pranlukast Intermediates |3'-[4-(4-Fenylbutoksy)benzoylamino]-2'-hydroxyacetofenon |CAS:136450-06-1 |C25H25NO4
-
3'-Amino-2'-hydroxyacetofenon 70977-72-9
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Respiratory sykten |Pranlukast Intermediates |3'-Amino-2'-hydroxyacetofenon |CAS: 70977-72-9 |C8H9NO2